...
首页> 外文期刊>Frontiers in Bioengineering and Biotechnology >Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases
【24h】

Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases

机译:纳米药物递送系统在心血管疾病治疗中的应用

获取原文
           

摘要

Cardiovascular diseases (CVDs) have become serious threat to human life and health. Though many drugs acting via different mechanism of action are available in the market as conventional formulations for the treatment of CVDs, they are still far from satisfactory due to poor water solubility, low biological efficacy, non-targeting and drug resistance. Nano-drug delivery systems (NDDSs) provide a new drug delivery method for the treatment of CVDs with the development of nanotechnology, demonstrating great advantages in solving the above problems. Nevertheless, there are some problems about NDDSs need to be addressed, such as cytotoxicity. In this review, the types and targeting strategies of NDDSs were summarized, and the new research progress in the diagnosis and therapy of CVDs in recent years was reviewed. Future prospective for nano-carriers in drug delivery for CVDs includes gene therapy, in order to provide more ideas for the improvement of cardiovascular drugs. In addition, its safety was also discussed in the review.
机译:心血管疾病(CVDS)对人类生活和健康造成严重威胁。尽管在市场上可获得不同的作用机制的许多药物作为常规制剂,但由于水溶性低,生物效力低,未靶向和耐药性,它们仍远远差不多。纳米药物递送系统(NDDS)提供了一种新的药物递送方法,用于治疗CVDS,随着纳米技术的发展,展示解决上述问题的巨大优势。然而,需要解决NDDS的一些问题,例如细胞毒性。在本综述中,综述了NDDSS的类型和定位策略,综述了近年来CVDS诊断和治疗的新研究进展。用于CVDS药物递送中纳米载体的未来前瞻性包括基因治疗,以便为改善心血管药物提供更多思路。此外,还在审查中讨论了其安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号